Skip to main content
SpringerLink
Log in

Erythroderma

  • Chapter
  • First Online:
Buka's Emergencies in Dermatology

Abstract

Erythroderma (exfoliative dermatitis) is a clinical syndrome characterized by extensive erythema involving greater than 90 % of the skin surface. It may be the result of many different dermatological conditions including preexisting dermatoses, drug reactions, and malignancy. Hospitalization may be required for initial evaluation and treatment since many of these patients are elderly and the skin involvement is extensive leading to significant mortality risk. Patients need to be monitored to ensure that temperature, water, protein, and electrolyte homeostasis are maintained. Erythroderma accounts for 1 % of all dermatologic hospital admissions [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bruno TF, Grewal P. Erythroderma: a dermatologic emergency. CJEM. 2009;11:244–6.

    PubMed  Google Scholar 

  2. Hasan T, Jansen CT. Erythroderma: a follow up of fifty cases. J Am Acad Dermatol. 1983;8:836–40.

    Article  PubMed  CAS  Google Scholar 

  3. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: a clinical study of 97 cases. BMC Dermatol. 2005;5:5.

    Article  PubMed  Google Scholar 

  4. Botella-Estrada R, Sanmartin O, Oliver V, Febrer I, Aliaga A. Erythroderma: a clinicopathical study of 56 cases. Arch Dermatol. 1994;130:1503–7.

    Article  PubMed  CAS  Google Scholar 

  5. Sehgal V, Srivastava G, Sardana K. Erthroderma/exfoliative dermatitis: a synopsis. Int J Dermatol. 2004;43:39–47.

    Article  PubMed  Google Scholar 

  6. Vonderheid E. Chronic generalized erythroderm. In: Lebwohl M, editor. Difficult diagnoses in dermatology. London: Churchill Livingstone; 1988. p. 89–100.

    Google Scholar 

  7. Karakayli G, Backham G, Orengo I, Rosen T. Exfoliative dermatitis. Am Fam Physician. 1999;59:625–30.

    PubMed  CAS  Google Scholar 

  8. Nicolis GD, Helwig EB. Exoliative dermatitis. A clinicopathologic study of 135 cases. Arch Dermatol. 1973;108:788–97.

    Article  PubMed  CAS  Google Scholar 

  9. Sigurdsson V, Toonstra J, Hezemans-Boer M, van Vloten W. Erythroderma: a clinical and follow-up study of 102 patients with special emphasis on survival. J Am Acad Dermatol. 1996;35:53–7.

    Article  PubMed  CAS  Google Scholar 

  10. Yuan X, Guo Y, Dang Y, Qiao L, Liu W. Erythroderma: a clinical-etiological study of 82 cases. Eur J Dermatol. 2010;20:373–7.

    PubMed  Google Scholar 

  11. Abrahams I, McCarthy JT, Sanders SL. 101 cases of exfoliative dermatitis. Arch Dermatol. 1963;87:96–101.

    Article  PubMed  CAS  Google Scholar 

  12. King Jr LE, Dufresne Jr RG, Lovett GL, Rosin MA. Erythroderma: review of 82 cases. South Med J. 1986;79:1210–5.

    Article  PubMed  Google Scholar 

  13. Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol. 1998;37:104–7.

    Article  PubMed  CAS  Google Scholar 

  14. Sehgal VN, Srivastava G. Exfoliative dermatitis. A prospective study of 80 patients. Dermatologica. 1986;173:278–84.

    Article  PubMed  CAS  Google Scholar 

  15. Rym BM, Mourad M, Bechir Z, et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol. 2005;44:731–5.

    Article  PubMed  Google Scholar 

  16. Eugster R, Kissling S, Brand CU. Clinical aspects and etiology of erythroderma: an analysis of 64 cases. Schweiz Rundsch Med Prax. 2001;90:1449–54.

    CAS  Google Scholar 

  17. Alonso-Llamazares J, Dietrich SM, Gibson LE. Bullous pemphigoid presenting as exfoliative erythroderma. J Am Acad Dermatol. 1998;39:827–30.

    Article  PubMed  CAS  Google Scholar 

  18. Glassman BD, Muglia JJ. Widespread erythroderma and desquamation in a neonate. Congenital cutaneous candidiasis. Arch Dermatol. 1993;129:902.

    Article  Google Scholar 

  19. Muller CS, Lorenz MT, Tigen W, Rass K. Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma. Int J Dermatol. 2010;49:676–8.

    Article  PubMed  Google Scholar 

  20. Marsch WC, Stuttgen G. Generalized Hailey-Hailey disease. Br J Dermatol. 1978;9:553–60.

    Article  Google Scholar 

  21. Arslanpence I, Dede FS, Gokcu M, Gelisen O. Impetigo herpetiformis unresponsive to therapy in a pregnant adolescent. J Pediatr Adolesc Gynecol. 2003;16:129–32.

    Article  PubMed  Google Scholar 

  22. Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos CE. Cutaneous mastocytosis in adults. Evaluation of 14 patients with respect to systemic disease manifestations. Dermatology. 1998;197:101–8.

    Article  PubMed  CAS  Google Scholar 

  23. Zachariae H, Sogaard H. Progressive generalized perforating folliculitis. Dermatological. 1984;168:131–7.

    Article  CAS  Google Scholar 

  24. Kodym E, Kalinska R, Ehringfeld C, Sterbik-Lamina A, Kodym R, Hohenberg G. Frequency of radiation recall dermatitis in adult cancer patients. Onkologie. 2005;28:18–21.

    Article  PubMed  Google Scholar 

  25. Mutasim DF. Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol. 2003;48:947–9.

    Article  PubMed  Google Scholar 

  26. Boyd AS, Menter A. Erythrodermic psoriasis. Precipitating factors, course and prognosis in 50 patients. J Am Acad Dermatol. 1989;21:985–91.

    Article  PubMed  CAS  Google Scholar 

  27. Goeckerman WH, O’Leary PA. Erythroderma psoriaticum. A review of 22 cases. JAMA. 1932;99:2102–5.

    Article  Google Scholar 

  28. Gaylor ML, Duvic M. Generalized pustular psoriasis following withdrawal of efalizsumab. J Drugs Dermatol. 2004;3:77–9.

    PubMed  Google Scholar 

  29. Rothe MJ, Bernstein ML, Grant-Kels J. Life-threatening erythroderma: diagnosing and treating the “red man”. Clin Dermatol. 2005;23:206–17.

    Article  PubMed  Google Scholar 

  30. Smith KJ, Decker C, Yeager J, Skelton HG, Baskin S. Therapeutic efficacy of carbamazepine in a HIV-1 positive patient with psoriatic erythroderma. J Am Acad Dermatol. 1997;37:851–4.

    Article  PubMed  CAS  Google Scholar 

  31. Shuster S, Marks J. Dermatopathic anaemia. Br J Dermatol. 1967;79:393–7.

    Article  PubMed  CAS  Google Scholar 

  32. Kannangara DW, Smith B, Cohen K. Exfoliative dermatitis during cefoxitin therapy. Arch Intern Med. 1982;142:1031–2.

    Article  PubMed  CAS  Google Scholar 

  33. Tietze KJ, Gaska JA. Cefoxitin-associated exfoliative dermatitis. Clin Pharm. 1983;2:582–4.

    PubMed  CAS  Google Scholar 

  34. Pavithran K. Exfoliative dermatitis after clofazimine. Int J Lepr Other Mycobact Dis. 1985;53:645–6.

    PubMed  CAS  Google Scholar 

  35. Patki AH, Menta JM. Dapsone-induced erythroderma with Beau’s line. Lepr Rev. 1989;60:274–7.

    PubMed  CAS  Google Scholar 

  36. Rao PN, Lakshmi TS. Increased in the incidence of dapsone hypersensitivity syndrome—an appraisal. Lepr Rev. 2001;72:57–62.

    PubMed  CAS  Google Scholar 

  37. Batinac T, Zamolo G, Jonjic N, et al. Angioimmunoblastic lymphodenopathy with dysproteinemia following doxycycline administration. Tumori. 2003;89:91–5.

    PubMed  Google Scholar 

  38. Guin JD, Phillips D. Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis. 1989;43:564–7.

    PubMed  CAS  Google Scholar 

  39. Khaled A, Sellami A, Fazaa B, Kharfi M, Zeglaoui F, Kamoun MR. Acquired erythroderma in adults: a clinical and prognostic study. J Eur Acad Dermatol Venereol. 2010;24:781–8.

    Article  PubMed  CAS  Google Scholar 

  40. Puig LL, Abadia M, Alomar A. Erythroderma due to ribostamycin. Contact Dermatitis. 1989;21:79–82.

    Article  PubMed  CAS  Google Scholar 

  41. Paul C, Janier M, Carlet J, et al. Erythroderma induced by teicoplanin. Ann Dermatol Venereol. 1992;119:667–9.

    PubMed  CAS  Google Scholar 

  42. Gupta AK, Lynde CW, Lauzon GJ, et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and review of the literature. Br J Dermatol. 1998;138:529–32.

    Article  PubMed  CAS  Google Scholar 

  43. Just M, Carrascosa JM, Ribera M, Bielsa I, Ferrandiz C. Dideoxyinosine-associated Ofuji papuloerythroderma in an HIV-infected patient. Dermatology. 1997;195:410–1.

    Article  PubMed  CAS  Google Scholar 

  44. Rietsema WJ. Fever, erythroderma, abdominal pain, and renal failure following initiation of indinavir therapy. Clin Infect Dis. 1997;25:1268–9.

    Article  PubMed  CAS  Google Scholar 

  45. Duque S, de la Puente J, Rodriguez F, Fernandez Pellon L, Maquiera E, Jerez J. Ziovudine-related erythroderma and successful desensitization: a case report. J Allergy Clin Immunol. 1996;98:234–5.

    Article  PubMed  CAS  Google Scholar 

  46. Friedman B, Orlet HK, Still JM, Law E. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J. 2002;95:1213–4.

    PubMed  Google Scholar 

  47. Chan LK, Winearls CG, Oliver DO, Dunnill MS. Acute interstitial nephritis and erythroderma associated with diflunisal. Br Med J. 1980;280:84–5.

    Article  PubMed  CAS  Google Scholar 

  48. Bernedo N, Audicana MT, Uriel O, et al. Metamizol as a cause of postoperative erythroderma. Contact Dermatitis. 2004;50:317–8.

    Article  PubMed  CAS  Google Scholar 

  49. Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-bases system for spontaneous reporting of adverse reactions to drugs. JAMA. 1984;252:1433–7.

    Article  PubMed  CAS  Google Scholar 

  50. Wittal RA, Fischer GO, Georgouras KE, Baird PJ. Skin reactions to diltiazem. Australas J Dermatol. 1992;33:11–8.

    Article  PubMed  CAS  Google Scholar 

  51. Ahearn GS, Selim MA, Tapson VF. Severe erythroderma as a complication of continuous epoprostenol therapy. Chest. 2002;122:379–80.

    Google Scholar 

  52. Reynolds NJ, Jones SK, Crossley J, Harman RR. Exfoliative dermatitis due to nifedipine. Br J Dermatol. 1989;121:401–4.

    Article  PubMed  CAS  Google Scholar 

  53. Cox NH, Gordon PM, Dodd H. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br J Dermatol. 2002;146:1061–3.

    Article  PubMed  CAS  Google Scholar 

  54. Hurley SC. Lamotrigine update and its use in mood disorders. Ann Pharmacother. 2002;36:860–72.

    Article  PubMed  CAS  Google Scholar 

  55. Fine JD, Breathnach SM. Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy. Arch Dermatol. 1986;122:199–200.

    Article  PubMed  CAS  Google Scholar 

  56. Yantis PL, Bridges ME, Pittman FE. Cimetidine-induced exfoliative dermatitis. Dig Dis Sci. 1980;25:73–4.

    Article  PubMed  CAS  Google Scholar 

  57. Catlin DH, Sekera M, Adelman DC. Erythroderma associated with ingestion of an herbal product. West I Med. 1993;159:491–3.

    CAS  Google Scholar 

  58. Cuxart M, Just M, Sans R. Generalized exfoliative dermatitis caused by erythropoietin. Med Clin (Barc). 2000;115:158.

    CAS  Google Scholar 

  59. Sparsa A, Bedane C, Benazahary H, et al. Drug hypersensitive syndrome caused by fluidione. Ann Dermatol Venereol. 2001;128:1014–8.

    PubMed  CAS  Google Scholar 

  60. Wantzin GL, Thomsen K. A new cutaneous side effect of isotretinoin. J Am Acad Dermatol. 1985;13:665.

    Article  PubMed  CAS  Google Scholar 

  61. Rebuck JA, Rybak MJ, Ramos DP, Weingarten CM. Omeprazole-induced exfoliative dermatitis. Pharmotherapy. 1998;18:877–9.

    CAS  Google Scholar 

  62. Gonzalo-Garijo MA, Perez-Calderon R, de Argila D, Rodriguez-Nevado I. Erythroderma to pseudoephedrine in a patient with contact allergy to phenylephrine. Allergol Immunopathol. 2002;30:239–42.

    CAS  Google Scholar 

  63. Shelley WB, Shelley ED. Chronic erythroderma induce by ®(beta)-blocker (timolol maleate) eyedrops. J Am Acad Dermatol. 1997;37:799–800.

    Article  PubMed  CAS  Google Scholar 

  64. Polyzos A, Tsavaris N, Kosmas C, et al. Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology. 2001;61:129–33.

    Article  PubMed  CAS  Google Scholar 

  65. Lee TC, Hook CC, Long HJ. Severe exfoliative dermatitis associated with hand ischemia during cisplatin therapy. Mayo Clin Proc. 1994;69:80–2.

    PubMed  CAS  Google Scholar 

  66. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol. 1995;33:393–410.

    Article  PubMed  CAS  Google Scholar 

  67. Bielsa I, Teixido J, Ribera M, Ferrandiz C. Erythroderma due to thalidomide: report of two cases. Dermatology. 1994;189:179–81.

    Article  PubMed  CAS  Google Scholar 

  68. Hall VC, El-Azhary RA, Bouwhuls S, Rajkumar SV. Dermatologicside effects of thalidomide in patients with multiple myeloma. J Am Acad Dermatol. 2003;48:548–52.

    Article  PubMed  Google Scholar 

  69. De Coninck A, De Hou MF, Peters O, Van Camp B, De Roseeuw DI. Aleukemic leukemia cutis. An ususual presentation of acute myelomonocytic leukemia. Dermatologica. 1986;172:272–5.

    Article  PubMed  Google Scholar 

  70. Hashizume H, Nakayama F, Oku T, Takigawa M. Adult T-cell leukemia with regression of erythroderma and simultaneous emergence of leukemia. J Am Acad Dermatol. 1992;27:846–9.

    Article  PubMed  CAS  Google Scholar 

  71. Granjo E, Lima M, Lopes JM, et al. Chronic eosinophilic leukaemia presenting with Erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report. Acta Haematol. 2002;107:108–12.

    Article  PubMed  CAS  Google Scholar 

  72. Artia K, Akiyama M, Sakai T, Shimizu H. Severely hyperkeratotic erythroderma associated with Hodgkin’s disease: does a high serum level of granulocyte-colony stimulating factor contribute to formation of skin lesions? J Am Acad Dermatol. 2003;49:772–3.

    Article  Google Scholar 

  73. Leong AS, Cowled PA, Zalewski PD, Burry JN, Meredith DJ, Forbes IJ. Erythroderma, an unusual manifestation of B cell lymphoma. Br J Dermatol. 1978;99(1):99–106.

    Article  PubMed  CAS  Google Scholar 

  74. Denton K, Wilson CL, Venning VA. Primary cutaneous anaplastic large-cell lymphoma with a prolonged erythrodermic prodrome. Br J Dermatol. 1992;126: 297–300.

    Article  PubMed  CAS  Google Scholar 

  75. Chu P, Aitchison R, Jones PA. Myelodysplasia presenting as erythroderma. Postgrad Med J. 1987;63:481–2.

    Article  PubMed  CAS  Google Scholar 

  76. Thestrup-Pedersen K, Halkier-Sorensen L, Sogaard H, Zachariae H. The red man syndrome. Exfoliative dermatitis of unknown etiology: a description and follow up of 38 patients. J Am Acad Dermatol. 1988;18:1307–12.

    Article  PubMed  CAS  Google Scholar 

  77. Nishijima S. Papuloerythroderma associated with hepatocellular carcinoma. Br J Dermatol. 1998;139:1115–6.

    Article  PubMed  CAS  Google Scholar 

  78. Axelrod JH, Herbold DR, Freel JH, Palmer SM. Exfoliative dermatitis: a presenting sign of fallopian tube carcinoma. Obstet Gynecol. 1988;71:1045–7.

    PubMed  CAS  Google Scholar 

  79. Deffer TA, Overton-Keary PP, Goette DK. Erythroderma secondary to esophageal carcinoma. J Am Acad Dermatol. 1985;13:311–3.

    Article  PubMed  CAS  Google Scholar 

  80. Harper TG, Latuska RF, Sperling HV. An unusual association between erythroderma and an occult gastric carcinoma. Am J Gastroenterol. 1984;79:921–3.

    PubMed  CAS  Google Scholar 

  81. Thami GP, Sharma NL, Sharma A, Sharma RC. Exfoliative dermatitis and malignant melanoma: coincidence or association. Int J Dermatol. 1996;35:682.

    Article  PubMed  CAS  Google Scholar 

  82. Antony FC, Ardern-Jones M, Evans AV, Rosenbaum T, Russell-Jones R. Giant condyloma of Buschke-Loewenstein in association with erythroderma. Clin Exp Dermatol. 2003;28:46–9.

    Article  PubMed  CAS  Google Scholar 

  83. Duncan SC, Winkelmann RK. Circulating Sézary cells in hospitalized dermatology patients. Br J Dermatol. 1978;99:171–8.

    Article  PubMed  CAS  Google Scholar 

  84. Zinzani PL, Ferreri AJ, Cerroni L. Mycosis fungoides. Crit Rev Oncol Hematol. 2008;65:172–82.

    Article  PubMed  Google Scholar 

  85. Wieselthier JS, Kohn HK. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol. 1990;22:381–401.

    Article  PubMed  CAS  Google Scholar 

  86. Vonderheld EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas. J Am Acad Dermatol. 2002;46:95–106.

    Article  Google Scholar 

  87. Wilson DC, Jester JD, King LE. Erythroderma and exfoliative dermatitis. Clin Dermatol. 1993;11:67–72.

    Article  PubMed  CAS  Google Scholar 

  88. Satoh H, Yamashita YT, Ohtsuka M, Sekizawa K. Post-irradiation erythroderma. Clin Oncol. 2000;12:336.

    CAS  Google Scholar 

  89. Ito K, Fujita M, Norioka M, et al. Postoperative erythroderma with change of HLA phenotypes from heterozygotes to homozygotes: a report of two cases. Eur J Haematol. 1991;46:217–22.

    Article  PubMed  CAS  Google Scholar 

  90. Sigurdsson V, de Vries IJ, Toonstra J, et al. Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol. 2000;27:436–40.

    Article  PubMed  CAS  Google Scholar 

  91. Sigurdsson V, Toonstra J, Bihari IC, Bruijnzeel-Koomen CA, van Vloten WA, Thepen T. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. A immuno-histochemical study. J Cutan Pathol. 2000;27:429–35.

    Article  PubMed  CAS  Google Scholar 

  92. Kanthraj GR, Srinivas CR, Devi PU, et al. Quantitative estimation and recommendations for supplementation of protein lost through scaling in exfoliative dermatitis. Int J Dermatol. 1999;38:91–5.

    Article  PubMed  CAS  Google Scholar 

  93. Hild DH. Folate losses from the skin in exfoliative dermatitis. Arch Intern Med. 1969;123:51–7.

    Article  PubMed  CAS  Google Scholar 

  94. Griffiths TW, Stevens SR, Cooper KD. Acute erythroderma as an exclusion criterion for idiopathic CD4+ T lymphocytopenia. Arch Dermatol. 1994;130:1530–3.

    Article  PubMed  CAS  Google Scholar 

  95. Preesman AH, Schrooyen SJ, Toonstra J, et al. The diagnostic value of morphometry on blood ­lymphocytes in erythrodermic actinic reticuloid. Arch Dermatol. 1995;131:1298–303.

    Article  PubMed  CAS  Google Scholar 

  96. Bakels V, van Oostveen JW, Preesman AH, Meijer CJ, Willemze R. Differentiation between actinic reticuloid and cutaneous T cell lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J Clin Pathol. 1998;51:154–8.

    Article  PubMed  CAS  Google Scholar 

  97. Fraser-Andrews EA, Russell-Jones R, Woolford AJ, Wolstencroft RA, Dean AJ, Whitttaker SJ. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome. Cancer. 2001;92:1745–52.

    Article  PubMed  CAS  Google Scholar 

  98. Cherny S, Mraz S, Su L, Harvell J, Kohler S. Heteroduplex analysis of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for erythroderma. J Cutan Pathol. 2001;28:351–5.

    Article  PubMed  CAS  Google Scholar 

  99. Walsh NM, Prokopetz R, Tron VA, et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol. 1994;21:419–23.

    Article  PubMed  CAS  Google Scholar 

  100. Ram-Wolff C, Martin-Garcia N, Bensussan A, Bagot M, Ortonne N. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am J Dermatopathol. 2010;32:755–63.

    Article  PubMed  Google Scholar 

  101. Zip C, Murray S, Walsh NM. The specificity of histopathology in erythroderma. J Cutan Pathol. 1993;2:393–8.

    Article  Google Scholar 

  102. Aatlo-Korte K, Turpeinen M. Quantifying systemic absorption of topical hydrocortisone in erythroderma. Br J Dermatol. 1995;133:403–8.

    Article  Google Scholar 

  103. Teshima D, Ikesue H, Itoh Y, Urabe K, Furue M, Oishi R. Increased topical tacrolimus absorption in generalized leukemic erythroderma. Ann Pharmacother. 2003;37:1444–7.

    Article  PubMed  Google Scholar 

  104. Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62:655–62.

    Article  PubMed  CAS  Google Scholar 

  105. Olsen EA, Rook AH, Zic J, et al. Sézary syndrome: immunopathogenesis, literature review of therapeutic option and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol. 2011;64:352–404.

    Article  PubMed  Google Scholar 

  106. Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis and erythroderma and in healthy control subjects. J Am Acad Dermatol. 2005;53:67–72.

    Article  PubMed  Google Scholar 

  107. Green MS, Prystowsky JH, Cohen SR, Cohen JI, Lebwohl MG. Infectious complications of erythrodermic psoriasis. J Am Acad Dermatol. 1996;34: 911–4.

    Article  PubMed  CAS  Google Scholar 

  108. Posner LE, Fossieck Jr BE, Eddy JL, Bunn Jr PA. Septicemic complications of cutaneous T-cell lymphomas. Am J Med. 1981;71:210–6.

    Article  PubMed  CAS  Google Scholar 

  109. Voigt GC, Kronthal HL, Crounse RG. Cardiac output in erythrodermic skin disease. Am Heart J. 1966;72:615–20.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatolgy, Mt. Sinai School of Medicine, One Gustave L. Levy Place, 5 East 98th St. 5th floor, New York, NY, 10029, USA

    Gillian Heinecke B.S. & Mark Lebwohl M.D.

Authors
  1. Gillian Heinecke B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Lebwohl M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Lebwohl M.D. .

Editor information

Editors and Affiliations

  1. , Department of Dermatology, Mount Sinai School of Medicine, Front Street 220, New York, 10038, New York, USA

    Bobby Buka

  2. , Department of Dermatology, Mount Sinai School of Medicine, Front Street 220, New York, 10038, New York, USA

    Annemarie Uliasz

  3. , Dermatology, Jacobi Medical Center, Albert Einstein College of Medicine, Pelham Parkway South, Bronx, 10461, New York, USA

    Karthik Krishnamurthy

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Heinecke, G., Lebwohl, M. (2013). Erythroderma. In: Buka, B., Uliasz, A., Krishnamurthy, K. (eds) Buka's Emergencies in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5031-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5031-3_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5030-6

  • Online ISBN: 978-1-4614-5031-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation